Can contraindications compromise evidence-based, patient-centered clinical practice?

Canadian Journal of Clinical Pharmacology

Volumn 13, Issue 1, 2006, Pages

  Montori, Victor M ^a,b   Leung, Teresa W ^b   Devereaux, P J ^b   Schünemann, Holger J ^b,c   Akl, Elie A ^c   Gafni, Amiram ^b   Guyatt, Gordon H ^b  

^a Mayo Clinic   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Contraindications; Decision making; Drug label; Evidence based medicine

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; GLIBENCLAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; PARACETAMOL; SUMATRIPTAN; TRIPTAN DERIVATIVE; DRUG;

ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CREATININE BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG FATALITY; E-MAIL; EVIDENCE BASED PRACTICE; HEALTH SURVEY; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INTERNET; LACTIC ACIDOSIS; MEDICAL DECISION MAKING; META ANALYSIS; MIGRAINE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT DECISION MAKING; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTEMATIC REVIEW; THORAX PAIN; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; VASOSPASM; WEIGHT GAIN; DOCTOR PATIENT RELATION; DRUG LABELING; EVIDENCE BASED MEDICINE; HEALTH PERSONNEL ATTITUDE; QUESTIONNAIRE;

ATTITUDE OF HEALTH PERSONNEL; DRUG LABELING; EVIDENCE-BASED MEDICINE; HUMANS; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES;

EID: 33645807827     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Haynes RB, Devereaux PJ, Guyatt GH. Physicians' and patients' choices in evidence based practice. BMJ. Jun 8 2002;324(7350):1350.
2. Jones GC, Macklin JP, Alexander WD. Contraindications to the use of metformin. BMJ. Jan 4 2003;326(7379):4-5.
3. Misbin RI. The Phantom of Lactic Acidosis due to Metformin in Patients With Diabetes. Diabetes Care. Jul 2004;27(7):1791-1793.
4. Dodick D, Lipton RB, Martin V, et al. Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT1B/1D Agonists) in the Acute Treatment of Migraine. Headache. May 01, 2004 2004;44(5):414-425.
5. Dillman D. Mail and Internet Surveys: The Tailored Design Method. New York, NY: John Wiley & Sons; 2000.
6. Montori VM, Leung TW, Walter SD, Guyatt GH. Procedures that assess inconsistency in meta-analyses can assess the likelihood of response bias in multiwave surveys. J Clin Epidemiol.2005 Aug;58(8):856-8.
7. Drane JW. Imputing nonresponses to mail-back questionnaires. Am J Epidemiol. Oct 15 1991;134(8):908-912.
8. Grandjean P. Implications of the precautionary principle for primary prevention and research. Annu Rev Public Health. 2004;25:199-223.
9. Levine MN, Gafni A, Markham B, MacFarlane D. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med. Jul 1 1992;117(1):53-58.
10. Whelan T, Levine M, Willan A, et al. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA. Jul 28 2004;292(4):435-441.